DexCom, Inc. (DXCM) vs Incyte Corporation (INCY)
INCY leads on 12 of 16 compared metrics.
A side-by-side comparison of DexCom, Inc. and Incyte Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 9, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — DXCM vs INCY
growth of $100 · last 21yDXCM +2419.0%INCY +1551.5%DXCM compounded faster
DXCM INCY
DXCM vs INCY: by the numbers
- •DXCM is the larger company ($28.18B vs $23.68B market cap).
- •INCY trades at the lower earnings multiple (16.56 vs 31.65 P/E).
- •INCY converts more revenue to profit (26.71% vs 19.31% net margin).
- •DXCM grew revenue faster over the past five years (18.91% vs 14.68% CAGR).
Which is better, DXCM or INCY?
Metric tally: DXCM 4 · INCY 12It depends on what you're optimizing for:
ValueINCY(lower P/E)
GrowthDXCM(faster 5Y revenue CAGR)
QualityINCY(higher ROIC)
Metrics side by side
Valuation
| Metric | DXCM | INCY |
|---|---|---|
| P/E ratio | 31.65 | 16.56● |
| Forward P/E | 28.55 | 15.33● |
| P/S ratio | 6.05 | 4.52● |
| P/B ratio | 9.86 | 4.37● |
| PEG ratio | 0.67● | 0.78 |
| EV / EBITDA | 22.76 | 13.48● |
| FCF yield | 4.90% | 5.98%● |
Profitability
| Metric | DXCM | INCY |
|---|---|---|
| Gross margin | 61.84% | 92.48%● |
| Operating margin | 21.45% | 27.05%● |
| Net margin | 19.31% | 26.71%● |
| ROE | 31.47%● | 25.79% |
| ROIC | 16.61% | 20.58%● |
Growth (annualized)
| Metric | DXCM | INCY |
|---|---|---|
| Revenue CAGR (5Y) | 18.91%● | 14.68% |
| EPS CAGR (5Y) | 10.31% | 21.19%● |
| FCF CAGR (5Y) | 43.37%● | 20.60% |
| Total return CAGR (5Y) | -7.90% | 7.57%● |
Frequently asked
- Which is better, DXCM or INCY?
- It depends on your goal. value: INCY (lower P/E); growth: DXCM (faster 5Y revenue CAGR); quality: INCY (higher ROIC). Across all compared metrics, INCY leads 12 to 4.
- Is DXCM or INCY cheaper?
- On trailing earnings, INCY is cheaper: DXCM trades at a 31.65 P/E and INCY at 16.56.
- Which has grown faster, DXCM or INCY?
- Over the past five years, DXCM grew revenue faster — DXCM at a 18.91% CAGR versus INCY at 14.68%.
- Is DXCM or INCY more profitable?
- INCY runs the higher net margin — DXCM at 19.31% versus INCY at 26.71%.
- Which has been the better investment, DXCM or INCY?
- Over the past 10-year, DXCM delivered the higher annualized total return — DXCM at 14.15% versus INCY at 3.19%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
DexCom P/E ratioIncyte P/E ratioDexCom dividend yieldIncyte dividend yieldDexCom ROEIncyte ROEDexCom operating marginIncyte operating marginDexCom revenue growthIncyte revenue growthDexCom free cash flowIncyte free cash flow
DexCom & Incyte appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 9, 2026.